Cargando…

698. 8 Years of Infective Endocarditis in Intravenous and Non-Intravenous Drug Users a Single Center Experience

BACKGROUND: Despite advances in diagnosis and management, infective endocarditis (IE) is associated with considerable morbidity and mortality. Given the emergence of drug- resistant organisms, it is unclear whether this has impacted the characteristics and outcomes of IE among intravenous drug users...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alpizar-Rivas, Rodolfo M, Balda, Javier, Elarabi, Salwa, Jaber, Bertrand, Nader, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778004/ http://dx.doi.org/10.1093/ofid/ofaa439.890

Ejemplares similares

697. 8 Years of Characteristics and Outcomes of Patients with MRSA Endocarditis Based on Vancomycin Minimum Inhibitory Concentration: Experience at a Tertiary Care Hospital
por: Alpizar-Rivas, Rodolfo M, et al.
Publicado: (2020)

170. Predictors of Recurrent Infective Endocarditis in Intravenous Drug Users
por: Kongpakpaisarn, Kullatham, et al.
Publicado: (2019)

1096. Evaluation of Vancomycin Pharmacokinetics in Intravenous Drug Users
por: Weihs, Sayo, et al.
Publicado: (2021)

Relapse of Polymicrobial Endocarditis in an Intravenous Drug User
por: Wang’ondu, Ruth W., et al.
Publicado: (2011)

698. Contemporary Clinical Epidemiology of Pediatric Shigella and Campylobacter Infections in Houston, TX, 2019 and 2020
por: tabarani, christy, et al.
Publicado: (2021)

A case of Klebsiella oxytoca endocarditis in an intravenous drug user
por: Hauser, Naomi, et al.
Publicado: (2017)

921 Prevalence of Hepatitis C Infection and Epidemiology of Infective Endocarditis in Intravenous Drug Users in Central Kentucky
por: Gundelly, Praveen, et al.
Publicado: (2014)

1376. Cryptococcal Infection Presenting Solely as a Pleural Effusion
por: Alpizar-Rivas, Rodolfo M, et al.
Publicado: (2021)

293. Influence of a Pharmacist Led Treatment Algorithm for the Management of Staphylococcus Bacteremia
por: Lomanno, Jessica, et al.
Publicado: (2020)

176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
por: Taqi, Ahmad, et al.
Publicado: (2020)

698. Nacubactam Inhibits Class A β-lactamases
por: Barnes, Melissa D, et al.
Publicado: (2018)

Infective Endocarditis and Intravenous Drug Users: Never Was and Never Will Be Taken Lightly
por: Kansara, Tikal, et al.
Publicado: (2021)

Poor long-term outcomes of intravenous drug users with infectious endocarditis
por: Caceres, Juan, et al.
Publicado: (2022)

Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users
por: Sadaqa, Dana, et al.
Publicado: (2023)

602. Intravenous Push Versus Intravenous Piggyback Administration of Cephalosporin Antibiotics: Impact on Safety, Workflow, and Cost
por: Lee, Ryan, et al.
Publicado: (2021)

597. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs)
por: Martin, Clifford P, et al.
Publicado: (2021)

Acute endocarditis in intravenous drug users: a case report and literature review
por: Ji, Yan, et al.
Publicado: (2012)

Native right‐sided endocarditis in intravenous drug user: A case report
por: Franca, Hudson, et al.
Publicado: (2022)

621. Identifying Quality-Improvement Interventions to Improve Inpatient Intravenous Vancomycin Safety at an Academic Medical Center
por: Christensen, Sean, et al.
Publicado: (2021)

PT698. Shifting Excitation/Inhibition Balance in Autism Spectrum Disorder
por: Ajram, Laura, et al.
Publicado: (2016)

Surgical treatment of infective endocarditis in active intravenous drug users: a justified procedure?
por: Weymann, Alexander, et al.
Publicado: (2014)

Massive Hemoptysis and Recurrent Infective Endocarditis in Intravenous Drug user: A Case Report
por: Almutairi, Mutlaq Deghaiman, et al.
Publicado: (2020)

191. oral versus Intravenous Antibiotic Treatment in Skin and Soft Tissue Infections as a Consequence of Intravenous Drug Use: A Retrospective Study to Demonstrate Noninferiority
por: Andrzejewski, Aryn M, et al.
Publicado: (2020)

698. Prevalence of Clostridioides difficile Infection in Patients with Isolated Glutamate Dehydrogenase (GDH) Positive
por: Pharnusopon, Tanadhol, et al.
Publicado: (2023)

Left-sided heart valve endocarditis in an intravenous drug user: Odd presentations and aggressive vegetations
por: Falconer, Jonathan, et al.
Publicado: (2019)

The cost of a recalcitrant intravenous drug user with serial cases of endocarditis: Need for guidelines to improve the continuum of care
por: Libertin, Claudia R., et al.
Publicado: (2017)

Mycobacterium tuberculosis infection in intravenous drug users recently diagnosed with HIV/AIDS
por: Popa, Ionuț, et al.
Publicado: (2013)

1025. Microbial Epidemiology of Infectious Endocarditis in the Intravenous Drug Abuse Population: A Retrospective Study in East Tennessee
por: Lorson, William, et al.
Publicado: (2018)

A Case of Necrotizing Fasciitis – Tapentadol Abuse Via Intravenous Route
por: maheswari, Latha, et al.
Publicado: (2022)

231. Retrospective Comparison of Intravenous Therapy, Oral Therapy, and Lipoglycopeptides for the Treatment of Osteomyelitis
por: Stumphauzer, Alex, et al.
Publicado: (2021)

198. Chart Validation of an Algorithm for Identifying Patients with Intravenous Drug Use-Associated Endocarditis Using Administrative Code Data
por: Kobayashi, Takaaki, et al.
Publicado: (2019)

HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs)
por: Jõgeda, Ene-Ly, et al.
Publicado: (2015)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users
por: Oprea, Cristiana, et al.
Publicado: (2014)

346. Eastern Equine Encephalitis and Use of Intravenous Immunoglobulin Therapy and High-Dose Steroids
por: Collens, Sarah I, et al.
Publicado: (2020)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

Surgical treatment of infective endocarditis in intravenous drug abusers
por: Zubarevich, Alina, et al.
Publicado: (2021)

Comparison of the effects of intravenous, enteral and enteral + intravenous supply of glutamine on malnutrition in sepsis
por: Koksal, G, et al.
Publicado: (2011)

1437. Short Versus Long-Course Intravenous Antibiotics for Young Infants with Urinary Tract Infection
por: Lawrence, Jolie, et al.
Publicado: (2021)

698. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Multidrug-Resistant Gram-Negative Bacilli
por: Goldberg, Joel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ph04isi5re8u1bfsglanbih5cf